Skip to main content
Unchecking box will stop auto data updates
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 112.25
Day High 115.15
Open:115.15
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions. United Therapeutics (UT) has an overarching commitment to environmental sustainability. The company's product candidates include Adcirca is a phosphodiesterase 5 (PDE-5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH)(WHO Group 1) to improve exercise ability in PAH patients. Orenitram is a prostacyclin vasodilator indicated for treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise capacity. Remodulin is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) to diminish symptoms associated with exercise. Tyvaso is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

United Therapeutics Corporation To Present At 37th Annual J.P. Morgan Healthcare Conference
PR Newswire - Mon Dec 31, 5:00AM CST
PR Newswire - PRNW
Mon Dec 31, 5:00AM CST
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , Dec. 31, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt , Ph.D., Chairman and Chief Executive Officer of United Therapeutics, will provide an overview and update on the company's business at the 37 th Annual J.P. Morgan Healthcare Conference in San Francisco, California .
United Therapeutics Corporation To Present At 37th Annual J.P. Morgan Healthcare Conference
PR Newswire - Mon Dec 31, 5:00AM CST
PR Newswire - CMTX
Mon Dec 31, 5:00AM CST
United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Chief Executive Officer of United Therapeutics, will provide an overview and update on the company's business at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, California.
United Therapeut Set to Possibly Pullback After Yesterday's Rally of 2.41%
Comtex SmarTrend(R) - Wed Dec 12, 11:22AM CST
Comtex SmarTrend(R) - CMTX
Wed Dec 12, 11:22AM CST
United Therapeut (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $110.91 to a high of $113.90. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $113.46 on volume of 89,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 100.06 +13.83% increase
on 12/24/18
Period Open:102.51
Price movement based on the high, low and last over the given period.
116.23 -2.00% decrease
on 01/16/19
+11.39 (+11.11%) increase
since 12/21/18
3-Month 100.06 +13.83% increase
on 12/24/18
Period Open:122.27
Price movement based on the high, low and last over the given period.
125.70 -9.39% decrease
on 10/31/18
-8.37 (-6.85%) decrease
since 10/22/18
52-Week 100.06 +13.83% increase
on 12/24/18
Period Open:143.46
Price movement based on the high, low and last over the given period.
143.73 -20.75% decrease
on 01/23/18
-29.56 (-20.61%) decrease
since 01/22/18

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

More stories below advertisement